Implants http://www.globalpost.com/taxonomy/term/34368/all en Industry and EU clash over medical devices regulation http://www.globalpost.com/dispatch/news/thomson-reuters/130220/industry-and-eu-clash-over-medical-devices-regulation <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>* Europe revisits rules after breast, hip implant scandals</p> <p>* Manufacturers fear new regulations will delay approvals</p> <p>* Debate centres on overhauling decentralised EU system</p> <p>By Ben Hirschler</p> <p>LONDON, Feb 20 (Reuters) - One year on from a breast implant scandal that shook confidence in Europe's light-touch system for regulating medical devices, lawmakers and manufacturers are at loggerheads on ways to protect patients from shoddy products.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130220/industry-and-eu-clash-over-medical-devices-regulation" target="_blank">read more</a></p> Implants Medicine Politics Prosthetics Thomson Reuters Wed, 20 Feb 2013 14:30:38 +0000 5761106 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130223/reuters-health-news-summary <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>FDA approves Roche drug for late-stage breast cancer</p> <p>WASHINGTON (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG &lt;ROG.VX&gt; for some patients with late-stage metastatic breast cancer who fail to respond to other therapies. The U.S. Food and Drug Administration said on Friday it had approved Kadcyla, also known as ado-trastuzumab emtansine, for patients whose cancer cells contain increased amounts of a protein known as HER2.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130223/reuters-health-news-summary" target="_blank">read more</a></p> Business Disaster Environment Health Hospitality Implants Labor Law Medicine Social Issues Weather Thomson Reuters Sat, 23 Feb 2013 06:00:31 +0000 5764043 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130223/reuters-health-news-summary-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>FDA approves Roche drug for late-stage breast cancer</p> <p>WASHINGTON (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG &lt;ROG.VX&gt; for some patients with late-stage metastatic breast cancer who fail to respond to other therapies. The U.S. Food and Drug Administration said on Friday it had approved Kadcyla, also known as ado-trastuzumab emtansine, for patients whose cancer cells contain increased amounts of a protein known as HER2.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130223/reuters-health-news-summary-0" target="_blank">read more</a></p> Business Disaster Environment Health Hospitality Implants Labor Law Medicine Social Issues Weather Thomson Reuters Sat, 23 Feb 2013 13:15:55 +0000 5764214 at http://www.globalpost.com Reuters Health News Summary http://www.globalpost.com/dispatch/news/thomson-reuters/130223/reuters-health-news-summary-1 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>Following is a summary of current health news briefs.</p> <p>FDA approves Roche drug for late-stage breast cancer</p> <p>WASHINGTON (Reuters) - U.S. health regulators approved a new drug made by Swiss drugmaker Roche Holding AG &lt;ROG.VX&gt; for some patients with late-stage metastatic breast cancer who fail to respond to other therapies. The U.S. Food and Drug Administration said on Friday it had approved Kadcyla, also known as ado-trastuzumab emtansine, for patients whose cancer cells contain increased amounts of a protein known as HER2.</p> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130223/reuters-health-news-summary-1" target="_blank">read more</a></p> Business Disaster Environment Health Hospitality Implants Labor Law Medicine Social Issues Weather Thomson Reuters Sat, 23 Feb 2013 21:31:00 +0000 5764542 at http://www.globalpost.com German firm on trial over faulty French breast implants http://www.globalpost.com/dispatch/news/afp/130322/german-firm-trial-over-faulty-french-breast-implants <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>Proceedings against a German safety standards firm that gave defective breast implants the all clear kicked off Friday in France, with millions of euros claimed in damages.</p> <p>TUV Rheinland had certified that implants made by Poly Implant Prothese (PIP) conformed to European safety rules, but the French firm shut in 2010 after it was found to have used substandard, industrial-grade silicone gel that caused abnormally high implant rupture rates.</p> <p>More than 400,000 women around the world are thought to have received implants made by PIP.</p> <p><a href="http://www.globalpost.com/dispatch/news/afp/130322/german-firm-trial-over-faulty-french-breast-implants" target="_blank">read more</a></p> Implants Medicine Prosthetics AFP Fri, 22 Mar 2013 12:46:07 +0000 5790941 at http://www.globalpost.com Kabang undergoes plastic surgery but can’t have snout replaced http://www.globalpost.com/dispatch/news/asianet/130409/kabang-undergoes-plastic-surgery-can-t-have-snout-replaced <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Asianet </div> </div> </div> <!--paging_filter--><p></p><P> The adage “You reap what you sow” has been proven to be true once more even if the one committing the good deed was just a dog.</p><P>Kabang’s good deed-saving the daughter and a niece of her owners from harm in December 2011 when she blocked the path of a speeding motorcycle-continues to spell good karma for the so-called “asong pinoy” (Filipino dog) or “aspin.”</p><P>After beating cancer last year, she is now on the road to full recovery and would soon be sent home from the University of California-Davis, where she underwent maxillofacial surgery on March 27.</p><P>During the five-hour </p> <p><a href="http://www.globalpost.com/dispatch/news/asianet/130409/kabang-undergoes-plastic-surgery-can-t-have-snout-replaced" target="_blank">read more</a></p> Business Implants Medical specialties Medicine Technology Asianet Tue, 09 Apr 2013 13:26:22 +0000 Asianet 5807122 at http://www.globalpost.com Hundreds expected for French breast implants mega-trial http://www.globalpost.com/dispatch/news/afp/130414/hundreds-expected-french-breast-implants-mega-trial <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>France will launch one its biggest-ever trials on Wednesday as five managers from company PIP face charges of selling faulty breast implants that sparked a global health scare.</p> <p>More than 5,000 women have registered as plaintiffs in the case, which sees the defendants including 73-year-old PIP founder Jean-Claude Mas charged with aggravated fraud for using industrial-grade silicone in implants.</p> <p>An estimated 300,000 women in 65 countries are believed to have received the implants, which are twice as likely to rupture as other brands.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130414/hundreds-expected-french-breast-implants-mega-trial" target="_blank">read more</a></p> Implants Medicine Prosthetics AFP Mon, 15 Apr 2013 02:01:08 +0000 5815616 at http://www.globalpost.com How PIP breast implant health scare, legal case unfolded http://www.globalpost.com/dispatch/news/afp/130414/how-pip-breast-implant-health-scare-legal-case-unfolded <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>France will launch one of its biggest-ever trials on Wednesday as five managers from company PIP face fraud charges for allegedly selling faulty breast implants that sparked global health fears.</p> <p>Here is how the health scare and criminal investigation unfolded:</p> <p>-- 2010 --</p> <p>- March 30: PIP is shut down and its product banned after it was revealed to have been using non-authorised silicone gel that caused abnormally high rupture rates of its implants.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130414/how-pip-breast-implant-health-scare-legal-case-unfolded" target="_blank">read more</a></p> Business Implants Labor Law Medicine PIP Prosthetics AFP Mon, 15 Apr 2013 02:01:34 +0000 5815622 at http://www.globalpost.com French executives on trial over faulty breast implants http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>France launched one its biggest-ever trials on Wednesday as five managers from company PIP faced charges of selling faulty breast implants that sparked a global health scare.</p> <p>More than 5,000 women registered as plaintiffs in the case, which sees the defendants including PIP founder Jean-Claude Mas charged with aggravated fraud for using industrial-grade silicone in implants.</p> <p>An estimated 300,000 women in 65 countries are believed to have received the implants, which some health authorities say are twice as likely to rupture as other brands.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants" target="_blank">read more</a></p> Implants Medicine Prosthetics AFP Wed, 17 Apr 2013 10:16:04 +0000 5818147 at http://www.globalpost.com French executives on trial over faulty breast implants http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants-0 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>France launched one of its biggest-ever trials on Wednesday as five managers from company PIP faced charges of selling faulty breast implants that sparked a global health scare.</p> <p>More than 5,000 women registered as plaintiffs in the case, which sees the defendants including PIP founder Jean-Claude Mas charged with aggravated fraud for using industrial-grade silicone in implants.</p> <p>An estimated 300,000 women in 65 countries are believed to have received the implants, which some health authorities say are twice as likely to rupture as other brands.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants-0" target="_blank">read more</a></p> Implants Medicine Prosthetics AFP Wed, 17 Apr 2013 10:31:44 +0000 5818163 at http://www.globalpost.com How PIP breast implant health scare, legal case unfolded http://www.globalpost.com/dispatch/news/afp/130417/how-pip-breast-implant-health-scare-legal-case-unfolded <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>The trial of five executives of breast implant company PIP, including its founder Jean-Claude Mas, opened in the French city of Marseille on Wednesday.</p> <p>Here is how the global health scare and criminal investigation unfolded:</p> <p>-- 2010 --</p> <p>- March 30: PIP is shut down and its product banned after it was revealed to have been using non-authorised silicone gel that caused abnormally high rupture rates of its implants.</p> <p>- June 10: 500 women who received the implants file a legal complaint against PIP in Marseille, near its corporate headquarters.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130417/how-pip-breast-implant-health-scare-legal-case-unfolded" target="_blank">read more</a></p> Business Implants Labor Law Medicine PIP Prosthetics AFP Wed, 17 Apr 2013 10:45:54 +0000 5818171 at http://www.globalpost.com Makers of fraudulent breast implants on trial in France http://www.globalpost.com/dispatch/news/thomson-reuters/130417/makers-fraudulent-breast-implants-go-trial-france <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Thomson Reuters </div> </div> </div> <!--paging_filter--><p>By Jean-François Rosnoblet</p> <p>MARSEILLE, France (Reuters) - Five French executives went on trial on Wednesday to jeers from victims for supplying women with hundreds of thousands of substandard breast implants and triggering a global health scare.</p> <p>More than 300,000 women around the world were fitted over a decade with implants from the French company Poly Implant Prothese (PIP), and the trial includes 5,000 civil plaintiffs and 300 lawyers.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://thomsonreuters.com" class="button wire reuters"></a></p> <p><span>Copyright Thomson Reuters, 2013.</span></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/thomson-reuters/130417/makers-fraudulent-breast-implants-go-trial-france" target="_blank">read more</a></p> Implants Jean-Claude Mas Medicine Prosthetics Thomson Reuters Wed, 17 Apr 2013 13:16:15 +0000 5818290 at http://www.globalpost.com French executives on trial over faulty breast implants http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants-1 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>France launched one of its biggest-ever trials on Wednesday as five managers from company PIP faced charges of selling faulty breast implants that sparked a global health scare.</p> <p>More than 5,000 women registered as plaintiffs in the case, which sees the defendants including PIP founder Jean-Claude Mas charged with aggravated fraud for using industrial-grade silicone in implants.</p> <p>An estimated 300,000 women in 65 countries are believed to have received the implants, which some health authorities say are twice as likely to rupture as other brands.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants-1" target="_blank">read more</a></p> Implants Medicine Prosthetics AFP Wed, 17 Apr 2013 14:16:00 +0000 5818355 at http://www.globalpost.com French executives on trial over faulty breast implants http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants-2 <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>France launched one of its biggest-ever trials on Wednesday as five managers from company PIP faced charges of selling faulty breast implants that sparked a global health scare.</p> <p>More than 5,000 women registered as plaintiffs in the case which sees the defendants, including PIP founder Jean-Claude Mas, charged with aggravated fraud for using industrial-grade silicone in implants.</p> <p>An estimated 300,000 women in 65 countries are believed to have received the implants, which some health authorities say are twice as likely to rupture as other brands.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130417/french-executives-trial-over-faulty-breast-implants-2" target="_blank">read more</a></p> Implants Medicine Prosthetics AFP Wed, 17 Apr 2013 15:46:45 +0000 5818451 at http://www.globalpost.com Indian baby with swollen head 'doing well' http://www.globalpost.com/dispatch/news/afp/130419/indian-baby-swollen-head-doing-well <div class="field field-type-text field-field-byline1"> <div class="field-items"> <div class="field-item odd"> Agence France-Presse </div> </div> </div> <!--paging_filter--><p>A 15-month-old Indian girl whose head has swollen to nearly double its normal size is "doing well", a doctor said Friday, but treatment could be complicated by the extreme nature of her case.</p> <p>Roona Begum, who suffers from hydrocephalus, a rare disorder that causes fluid to build up on the brain, was discovered earlier this month living with her parents who are too poor to pay for life-saving treatment.</p> <div class="field field-type-text field-field-wire-copyright"> <div class="field-items"> <div class="field-item odd"> <p><a href="http://www.afp.com/" class="button wire afp"></a></p> <p><a href="http://www.globalpost.com/terms-use#afp"><span>Copyright AFP, 2013.</span></a></p> </div> </div> </div> <p><a href="http://www.globalpost.com/dispatch/news/afp/130419/indian-baby-swollen-head-doing-well" target="_blank">read more</a></p> Health Hydrocephalus Implants Labor Medicine Social Issues Technology AFP Fri, 19 Apr 2013 07:00:37 +0000 5819961 at http://www.globalpost.com